INMB - INmune Bio Inc. Common stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
1.89 0.03 (1.6%)	---	---	-0.01 (-0.5%)	-0.01 (-0.53%)	0.07 (3.74%)	0.01 (0.53%)	0.01 (0.53%)

INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Market Period: Closed

Earnings & Ratios

Basic EPS:: -1.05
Diluted EPS:: -1.05
Basic P/E:: -1.8288
Diluted P/E:: -1.8288
RSI(14) 1m:: 0.0
VWAP:: 1.92
RVol:: 0.6282

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	1.91 -0.02 (-1.0%)	Oct 15 09:46
1m	Price increase 1m	1.94 +0.03 (+1.57%)	Oct 15 09:37
1m	Price increase 1m	1.93 +0.02 (+1.05%)	Oct 15 09:36
10m	Price increase 10m	1.93 +0.06 (+3.21%)	Oct 15 09:36